Security key
46489V302
Perspective Therapeutics, Inc. - Common Stock, par value $0.001 per share (CATX)
CUSIP: 46489V302
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 340
- Total 13F value
- $1,159
- Share change
- -246
- SEC-reported price per share
- $3.41
- Number of holders
- 1
- Value change
- -$839
- Number of sells
- 1
- Shares outstanding
- 113,811,233
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
CATX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Perspective Therapeutics, Inc. SEC filings
Perspective Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 46489V302
Recent filing periods:
Ownership snapshot
Top reported holders of CATX - Perspective Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Commodore Capital LP
Disclosed value leader
TCG Crossover Management,...
Comparable rows
15/15
Latest evidence
23 Jun 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Commodore Capital LP
Showing 1-6 of 15 holder rows.
Quick read
Commodore Capital LP leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Commodore Capital LP's linked filing trail.
Comparable ownership
Top 5
Commodore Capital LP
9.9%
TCG Crossover GP II, LLC
6.9%
Qatar Investment Authority
6.2%
Avidity Partners Management LP
5.3%
BlackRock, Inc.
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Commodore Capital LP |
13D/G
13F
Company
|
9.9%
|
$29,968,780
11,939,753 shares
|
$0 | 02 Feb 2026 |
| TCG Crossover GP II, LLC |
13D/G
Chen Yu
|
6.9%
|
$21,767,809
7,915,567 shares
|
$0 | 03 Feb 2026 |
| Qatar Investment Authority |
13D/G
|
6.2%
|
$19,451,597
7,073,308 shares
|
$0 | 04 Feb 2026 |
| Avidity Partners Management LP |
13D/G
13F
Company
|
5.3%
|
$29,523,995
6,049,999 shares
|
+$15,659,798 | 20 Feb 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
4.6%
from 13D/G
|
$22,303,498
5,348,561 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
4.3%
|
$17,764,795
4,893,883 shares
|
$0 | 23 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
340
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
136
Q2 2026 holders
1
Holder diff
-135
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend